ongo
middl
east
respiratori
syndrom
coronaviru
merscov
outbreak
pose
worldwid
public
health
threat
block
merscov
zoonot
transmiss
dromedari
camel
anim
reservoir
could
potenti
reduc
number
primari
human
case
report
merscov
transmiss
experiment
infect
llama
anim
directli
inocul
llama
shed
viru
least
day
could
infect
incontact
anim
day
exposur
aim
block
viru
transmiss
examin
efficaci
recombin
spike
vaccin
contrast
anim
incontact
vaccin
llama
shed
infecti
viru
upon
exposur
directli
inocul
llama
consist
induct
strong
viru
neutral
antibodi
respons
data
provid
evid
vaccin
reservoir
host
may
imped
merscov
zoonot
transmiss
human
middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
septemb
emerg
zoonot
pathogen
associ
sever
pneumonia
acut
respiratori
distress
syndrom
multiorgan
failur
human
result
fatal
outcom
septemb
world
health
organ
notifi
laboratoryconfirm
case
human
least
death
merscov
case
report
countri
mainli
middl
east
addit
major
outbreak
occur
south
korea
case
fatal
therefor
merscov
appear
current
worldwid
public
health
threat
dromedari
camel
main
reservoir
merscov
play
key
role
infect
primari
human
case
new
world
camelid
speci
merscov
infect
evidenc
presenc
merscov
neutral
antibodi
nab
furthermor
merscov
experiment
infect
alpaca
llama
confirm
could
serv
potenti
reservoir
due
high
human
lethal
rate
absenc
merscovlicens
vaccin
treatment
merscov
priorit
research
product
develop
r
blueprint
action
prevent
epidem
suggest
anim
vaccin
best
strategi
control
merscov
infect
sinc
reduct
viru
shed
potenti
prevent
animaltoanim
zoonot
transmiss
might
faster
develop
licens
pathway
compar
human
vaccin
current
merscov
vaccin
candid
mainli
use
entir
sub
region
spike
protein
code
gene
viru
surfac
structur
glycoprotein
bind
host
receptor
dipeptidyl
peptidas
subunit
therefor
target
choic
rais
nab
subunit
protein
immunogen
induc
tcell
mediat
nab
respons
mainli
direct
toward
receptor
bind
domain
rbd
also
name
b
domain
recent
report
although
nab
target
b
domain
antibodi
target
sialic
acid
bind
domain
domain
also
provid
protect
lethal
merscov
challeng
mous
model
sever
vaccin
prototyp
control
merscov
test
use
wide
varieti
deliveri
system
includ
dna
vaccin
proteinbas
vaccin
vectorbas
vaccin
live
attenu
vaccin
vectorbasedvaccin
develop
use
orthopox
modifi
viru
ankara
mva
differ
hostorigin
adenoviru
adv
measl
viru
mev
rabi
viru
rabv
venezuelan
equin
enceph
replicon
vrp
express
differ
length
protein
vectorbas
candid
test
human
transgen
transduc
mice
except
orthopoxbas
recombin
vaccin
express
fulllength
merscov
spike
protein
induc
effici
protect
immun
dromedari
due
retic
appli
live
genet
modifi
organ
protein
recombin
subunit
dna
vaccin
mainli
base
protein
gene
respect
also
studi
dnabas
vaccin
express
fulllength
protein
shown
induc
merscov
specif
nab
confer
protect
rhesu
macaqu
addit
merscov
proteinbas
vaccin
use
fulllength
fragment
protein
produc
form
viruslik
particl
nanoparticl
peptid
recombin
protein
partial
protect
efficaci
candid
demonstr
nonhuman
primat
nhp
transgen
mice
recent
studi
demonstr
protein
subunit
vaccin
confer
protect
merscov
strain
alpaca
model
although
dromedari
camel
vaccin
abl
reduc
delay
viral
shed
howev
evid
merscov
vaccin
candid
develop
far
abl
block
merscov
transmiss
camelid
test
directcontact
viru
transmiss
set
mimick
natur
transmiss
field
vaccin
merscov
anim
reservoir
potenti
reduc
transmiss
human
provid
simpl
econom
solut
avoid
expans
threaten
diseas
present
studi
show
effici
merscov
transmiss
among
llama
furthermor
success
use
directcontact
transmiss
model
demonstr
efficaci
recombin
vaccin
use
regist
adjuv
block
merscov
transmiss
experi
merscov
perform
biosafeti
facil
biocontain
unit
irtacresa
barcelona
spain
present
studi
approv
ethic
anim
welfar
committe
irta
ceeairta
ethic
commiss
anim
experiment
autonom
govern
catalonia
file
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
lonza
supplement
fetal
calf
serum
fc
euroclon
uml
penicillin
thermofish
scientif
life
technolog
ml
streptomycin
thermofish
scientif
life
technolog
mm
glutamin
thermofish
scientif
life
technolog
passag
merscov
stock
strain
propag
vero
cell
co
incub
day
infecti
viru
titr
determin
vero
cell
calcul
determin
dilut
caus
cytopath
effect
cpe
inocul
cell
cultur
tissu
cultur
infecti
dose
endpoint
tcid
fulllength
merscov
recombin
protein
includ
b
domain
produc
hous
use
baculoviru
hek
cell
product
system
previous
describ
brief
produc
solubl
merscov
use
baculoviru
express
system
gene
fragment
encod
merscov
subunit
amino
acid
emc
isol
genbank
access
codonoptim
insect
cell
express
clone
infram
honeybe
melittin
hbm
secret
signal
peptid
tripl
streptag
purif
tag
pfastbac
transfer
vector
gener
bacmid
dna
recombin
baculoviru
perform
accord
protocol
bactobac
system
invitrogen
express
merscov
perform
infect
recombin
baculoviru
cell
recombin
protein
harvest
cell
cultur
supernat
day
post
infect
purifi
use
streptactin
sepharos
affin
chromatographi
iba
product
recombin
hek
cell
describ
previous
brief
amino
acid
isol
genbank
access
encod
sequenc
ctermin
fuse
gene
fragment
encod
fc
region
human
igg
clone
pcagg
mammalian
express
vector
express
plasmid
transfect
cell
affin
purifi
cultur
supernat
use
proteina
affin
chromatographi
fc
part
fusion
protein
proteolyt
remov
thrombin
follow
proteina
affin
purif
use
thrombin
cleavag
site
present
junction
sixteen
healthi
llama
purchas
hous
irta
farm
facil
catalonia
spain
immun
period
transfer
challeng
anim
facil
biocontain
unit
irtacresa
barcelona
spain
five
llama
prime
vaccin
recombin
protein
produc
baculoviru
system
emulsifi
volum
isa
vg
seppic
adjuv
intramuscularli
administ
ml
per
anim
dose
right
side
neck
boost
immun
conduct
week
later
left
side
neck
recombin
protein
produc
hek
cell
emulsifi
volum
isa
vg
seppic
adjuv
correct
structur
antigen
previous
confirm
reactiv
conform
antibodi
solid
phase
sialic
acid
bind
assay
two
week
later
merscov
challeng
perform
experi
viru
transmiss
vaccin
efficaci
conduct
two
separ
box
box
group
llama
n
intranas
inocul
tcid
dose
merscov
strain
genbank
acces
ml
salin
solut
ml
nostril
use
nebul
devic
teleflex
inc
day
postinocul
dpi
llama
n
put
contact
infect
llama
figur
supplementari
fig
box
protocol
box
follow
use
vaccin
llama
n
contact
group
figur
box
set
previou
transmiss
studi
perform
pig
regard
nomenclatur
use
studi
anim
correspond
intranas
inocul
llama
box
respect
llama
contact
anim
llama
immun
contact
anim
anim
monitor
daili
clinic
sign
sneez
cough
nasal
discharg
dyspnea
rectal
temperatur
record
fast
display
digit
thermomet
day
postinocul
pi
anim
box
respect
llama
hous
box
nasal
swab
ns
obtain
daili
day
pi
box
ns
collect
daili
day
pi
two
extra
collect
perform
dpi
serum
sampl
obtain
first
second
immun
prior
challeng
weekli
merscov
challeng
anim
euthan
challeng
overdos
pentobarbit
extra
sampl
ns
perform
prior
necropsi
procedur
three
differ
type
environment
sampl
es
collect
determin
viral
load
box
throughout
studi
see
supplementari
fig
previous
describ
air
filter
devic
sartoriu
sartoriu
stedim
use
test
one
thousand
litr
air
min
lmin
air
volum
gelatin
membran
filter
one
wall
scrub
two
swab
water
sampl
drink
point
also
obtain
es
collect
daili
dpi
viral
rna
collect
sampl
detect
rtqpcr
previous
describ
briefli
ns
es
except
water
sampl
transfer
cryotub
contain
either
dmem
lonza
pb
lonza
supplement
uml
penicillin
thermofish
scientif
life
technolog
streptomycin
thermofish
scientif
life
technolog
vortex
store
use
water
sampl
directli
frozen
instead
viral
rna
ns
es
extract
rna
viru
kit
machereynagel
follow
manufactur
instruct
rna
extract
test
use
upe
pcr
rtqpcr
carri
use
agpathid
tm
onestep
rtpcr
reagent
appli
biosystem
life
technolog
amplif
done
use
fast
realtim
pcr
system
appli
biosystem
life
technolog
program
follow
min
sec
cycl
sec
sampl
quantif
cycl
cq
valu
consid
posit
merscov
rna
test
viral
replic
viral
rna
extract
form
ns
test
presenc
mrna
accord
previous
publish
protocol
coleman
et
al
viral
rna
sequenc
viral
rna
extract
llama
ns
use
qiaamp
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
cdna
produc
rna
use
superscript
iii
first
strand
synthesi
system
invitrogen
corp
use
random
hexam
cdna
use
templat
pcr
amplifi
merscov
spike
encod
region
nucleotid
posit
genbank
access
use
pfuultra
ii
fusion
hs
dna
polymeras
alig
technolog
pcr
carri
follow
min
cycl
sec
sec
sec
final
extens
min
amplicon
sequenc
bidirect
use
bigdy
termin
cycl
sequenc
kit
abi
prism
genet
analyz
appli
biosystem
ns
es
collect
differ
time
pi
evalu
presenc
infecti
viru
titrat
vero
cell
previous
report
tenfold
dilut
done
start
dilut
dilut
transfer
vero
cell
plate
daili
monitor
light
microscop
well
evalu
presenc
cpe
dpi
amount
infecti
viru
swab
calcul
determin
tcid
specif
serum
sampl
collect
timepoint
anim
determin
merscov
previous
describ
briefli
highbind
plate
sigmaaldrich
coat
protein
pb
block
bovin
serum
h
serum
sampl
test
dilut
follow
h
incub
plate
wash
time
pb
well
incub
goat
antillama
biotin
conjug
abcor
dilut
block
buffer
follow
incub
streptavidin
peroxidas
sigmaaldrich
h
incub
well
wash
time
pb
tmb
substrat
solut
sigmaaldrich
ad
allow
develop
min
room
temperatur
protect
light
optic
densiti
measur
nm
test
llama
sera
merscov
nucleocapsid
n
specif
antibodi
respons
use
luciferas
immunoprecipit
lip
assay
n
protein
express
ntermin
renilla
luciferas
ruc
tag
protein
rucn
use
express
vector
cell
lyse
luminesc
unit
lu
measur
cell
lysat
lip
assay
done
accord
previou
protocol
minor
modif
briefli
serum
sampl
dilut
mix
lu
rucn
total
volum
buffer
mm
tri
ph
mm
nacl
mm
mgcl
triton
mixtur
incub
rotari
shaker
h
room
temperatur
mixtur
transfer
multiscreenht
bv
filter
plate
merk
millipor
contain
suspens
ultralink
protein
ag
bead
incub
one
hour
well
wash
luminesc
measur
well
ad
coelenterazin
nanolight
technolog
assay
buffer
mm
potassium
phosphat
ph
mm
nacl
mm
edta
sera
test
duplic
least
two
independ
assay
data
averag
determin
lu
valu
sampl
test
llama
sera
vaccin
efficaci
studi
function
antibodi
sialic
acid
bind
ntermin
domain
nanoparticlebas
hi
assay
use
lumazin
synthas
ls
nanoparticl
produc
describ
previous
twofold
dilut
sera
mix
ha
unit
ls
incub
min
follow
incub
wash
turkey
rbc
ad
incub
h
hi
titr
determin
reciproc
highest
serum
dilut
show
inhibit
hemagglutin
test
llama
sera
vaccin
efficaci
studi
antibodi
abl
block
merscov
bind
receptor
use
competit
elisa
elisa
plate
coat
recombin
solubl
protein
overnight
plate
wash
pb
block
bsa
pb
h
serum
sampl
test
dilut
recombin
merscov
mix
dilut
sera
incub
hr
ad
plate
incub
h
plate
wash
hrplabel
rabbit
antimous
ig
ad
detect
bound
follow
h
incub
plate
wash
signal
detect
use
tmb
describ
optic
densiti
measur
nm
serum
sampl
nasal
swab
test
neutral
antibodi
merscov
isol
use
plaqu
reduct
neutral
prnt
assay
prnt
assay
carri
use
accord
previous
publish
protocol
modif
briefli
sampl
first
inactiv
min
serial
dilut
heatinactiv
serum
mix
viru
pfu
prior
overlay
onto
cell
h
infect
cell
fix
stain
use
mous
antimerscov
nucleocapsid
protein
sinobiolog
hrpconjug
goat
antimous
southernbiotech
number
infect
cell
detect
use
precipitateform
tmb
substrat
true
blue
kpl
count
use
imag
analys
ctl
europ
gmbh
prnt
titr
calcul
base
greater
reduct
infect
cell
count
three
six
directlyinocul
one
five
contact
llama
show
moder
nasal
mucu
secret
dpi
see
supplementari
fig
clinic
sign
notic
five
vaccin
llama
throughout
studi
despit
higher
basal
bodi
temperatur
anim
hous
box
inocul
nonvaccin
incontact
llama
show
signific
increas
bodi
temperatur
upon
merscov
challeng
box
inocul
vaccin
incontact
llama
bodi
temperatur
llama
remain
constant
along
experi
never
exceed
merscov
inocul
llama
shed
viral
rna
nasal
caviti
period
figur
b
amount
viral
rna
still
high
cq
valu
inocul
llama
dpi
decreas
rna
load
observ
dpi
onward
incontact
llama
box
reveal
evid
infect
detect
viral
rna
day
contact
viral
rna
load
durat
shed
similar
inocul
anim
figur
box
one
five
vaccin
llama
viral
rna
nasal
caviti
level
compar
nonvaccin
incontact
anim
four
anim
low
level
viral
rna
figur
addit
viral
rna
llama
sequenc
day
pi
use
compar
analysi
protein
see
supplementari
fig
substitut
serin
phenylalanin
found
amino
acid
posit
comparison
inoculum
isol
protein
see
supplementari
fig
mutat
also
found
anoth
vaccin
llama
dpi
interestingli
identifi
mutat
aris
dpi
three
directli
inocul
llama
furthermor
contact
anim
also
investig
mutat
found
llama
dpi
see
supplementari
fig
ensur
mutant
neutral
escap
mutant
mutant
viru
plaquepurifi
form
nasal
swab
llama
dpi
viru
sequenc
genbank
access
ensur
mutat
present
spike
protein
use
carri
neutral
assay
viru
neutral
serum
five
vaccin
anim
supplementari
fig
rtqpcr
posit
nasal
swab
sampl
test
presenc
infecti
viru
intranas
inocul
llama
excret
infecti
merscov
point
dpi
figur
durat
infecti
viru
shed
vari
among
individu
anim
rang
consecut
day
box
least
one
inocul
llama
anim
shed
infecti
viru
continu
day
pi
figur
three
five
direct
contact
llama
box
shed
infecti
viru
dpi
figur
nonvaccin
incontact
anim
exhibit
viru
titr
least
equal
observ
inocul
llama
figur
peak
viral
rna
coincid
highest
level
infecti
viru
shed
although
llama
merscov
mrna
indic
replic
nasal
caviti
level
compar
nonvaccin
incontact
anim
supplementari
fig
assess
specif
rtqpcr
describ
coleman
collabor
none
vaccin
anim
box
includ
llama
shed
infecti
viru
point
studi
figur
llama
show
low
level
merscov
rna
dpi
incontact
challeng
figur
howev
anim
remain
neg
rtqpcr
dpi
suggest
contamin
occur
collect
process
sampl
addit
infecti
viru
detect
anim
dpi
figur
rel
low
level
viral
rna
detect
type
environment
sampl
taken
box
experi
cq
tabl
highest
merscov
rna
level
found
drink
water
sampl
howev
titrat
infecti
viru
success
evalu
merscov
specif
antibodi
respons
induc
llama
follow
infect
vaccin
regard
transmiss
studi
directli
inocul
incontact
llama
seroconvert
merscov
detect
merscov
elisa
figur
viru
neutral
figur
contrast
three
two
directli
inocul
one
incontact
also
develop
antin
antibodi
respons
see
supplementari
fig
antibodi
sialic
acid
bind
domain
detect
one
directli
inocul
four
incontact
anim
use
hi
assay
figur
receptorbind
block
mainli
rbddirect
antibodi
detect
sera
directli
inocul
anim
four
five
incontact
llama
sera
use
competit
rbi
elisa
figur
follow
merscov
vaccin
vaccin
anim
figur
red
develop
high
titr
serum
antibodi
figur
viru
neutral
antibodi
clade
b
clade
isol
detect
prnt
figur
supplementari
fig
particular
vaccin
induc
antibodi
two
function
domain
bind
ntermin
domain
detect
hi
assay
figur
rbd
detect
competit
rbi
elisa
figur
addit
one
directli
inocul
none
vaccin
anim
develop
antibodi
n
protein
supplementari
fig
aim
assess
mucos
immun
elicit
upon
vaccin
evalu
presenc
antibodi
nasal
caviti
remark
detect
low
level
merscov
neutral
antibodi
nasal
swab
three
five
vaccin
anim
figur
f
studi
experiment
merscov
transmiss
infect
llama
incontact
llama
demonstr
first
time
consist
previou
studi
merscov
inocul
llama
got
infect
shed
infecti
viru
abl
transmit
viru
naiv
contact
anim
assess
merscov
rna
viral
titrat
nasal
swab
confirm
infect
llama
abl
transmit
merscov
least
anim
nonetheless
studi
need
determin
basic
reproduct
ratio
viru
transmiss
camelid
interestingli
three
contact
llama
shed
infecti
merscov
show
highest
viral
rna
load
remain
two
higher
cq
valu
infecti
viru
isol
altogeth
take
account
viral
genom
replic
observ
incontact
llama
extend
period
ii
incontact
anim
shed
detect
infecti
viru
iii
one
exhibit
nasal
discharg
incontact
model
viru
transmiss
valuabl
test
vaccin
efficaci
howev
state
llama
surrog
dromedari
vaccin
test
incontact
model
would
import
assess
whether
infecti
viral
pressur
elicit
experiment
challeng
similar
two
anim
speci
respect
previou
report
similar
found
present
studi
llama
infect
intranas
merscov
strain
base
vivo
protect
capac
monoclon
antibodi
direct
differ
domain
spike
protein
broader
protect
immun
respons
achiev
use
multidomain
vaccin
b
domain
compar
rbdfocus
vaccin
thu
efficaci
recombin
protein
emulsifi
adjuv
isa
vg
evalu
potenti
vaccin
candid
show
immun
llama
effici
protect
merscov
infect
infecti
viru
detect
nose
vaccin
anim
viral
rna
shed
remain
low
cq
except
one
llama
viral
mrna
also
detect
nasal
caviti
llama
might
intracellular
viral
mrna
cell
harvest
nasal
swab
nonetheless
could
detect
infecti
viru
neutral
viru
antibodi
mucos
level
may
inhibit
infecti
viral
particl
product
lack
detect
infecti
viru
vaccin
llama
despit
infect
render
anim
unlik
transmit
viru
anim
thu
block
transmiss
chain
addit
studi
reveal
mutat
spike
protein
encod
viral
rna
may
suggest
potenti
escap
variant
produc
howev
emerg
mutat
anoth
vaccin
llama
one
incontact
anim
three
directli
inocul
llama
reveal
addit
capac
vaccin
anim
induc
nab
variant
isol
indic
unlik
escap
variant
induc
antibodi
pressur
mutat
site
directli
involv
receptor
bind
previous
report
occur
result
viru
adapt
host
receptor
overal
indic
probabl
adapt
mutat
rather
vaccin
escap
mutat
immun
protein
induc
antibodi
rbd
confirm
rbi
viru
neutral
assay
well
antibodi
domain
confirm
hi
assay
latter
antibodi
may
import
block
viru
attach
sialic
acid
present
camelid
demonstr
dromedari
camel
upper
respiratori
tract
importantli
serum
nab
gener
vaccin
anim
boost
immun
maintain
challeng
therefor
correl
nab
level
serum
upon
vaccin
protect
occur
previous
describ
anoth
vaccin
studi
camelid
notabl
detect
mucos
nab
nasal
caviti
vaccin
llama
also
report
dromedari
camel
immun
mvabas
candid
addit
demonstr
vaccin
llama
spike
protein
clade
merscov
isol
provid
protect
challeng
clade
b
viru
islol
sinc
evid
merscov
reinfect
report
camel
field
studi
determin
whether
intramuscular
administr
subunit
vaccin
boost
mucos
immun
upper
respiratori
tract
anim
previous
expos
merscov
need
critic
compon
vaccin
influenc
durat
qualiti
immun
respons
adjuv
use
isa
vg
adjuv
shown
induc
longterm
protect
immun
larg
anim
speci
stimul
cellmedi
humor
immun
respons
studi
conduct
target
speci
order
determin
optim
antigen
dose
persist
nab
follow
recombin
vaccin
fact
two
dose
enough
induc
protect
oppos
recent
studi
use
dose
antigen
combin
adjuv
unlik
vectorbas
vaccin
proteinbas
vaccin
requir
safeti
test
high
contain
facil
field
studi
could
directli
conduct
thu
reduc
cost
propos
vaccin
regist
adjuv
use
studi
isa
vg
offer
econom
practic
use
field
applic
therefor
recombin
vaccin
test
studi
appear
good
candid
prevent
animaltoanim
eventu
animaltohuman
transmiss
overal
work
reveal
llama
model
surrog
dromedari
camel
merscov
transmiss
vaccin
studi
moreov
immun
merscov
recombin
protein
combin
commerci
adjuv
effici
limit
infecti
viral
shed
vaccin
llama
upon
exposur
directli
inocul
one
